Jonathan M. Meyer, Stephen M. Stahl

The Clinical Use of Antipsychotic Plasma Levels

• Broschiertes Buch

Produktbeschreibung

The first clinically oriented handbook on using antipsychotic levels for managing adherence and optimizing treatment effectiveness. Covers concepts of response threshold, the point of futility and correlations between antipsychotic dosages and trough levels. For all clinicians working with psychiatric patients receiving antipsychotic therapy.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Stahl's Essential Psychopharmacology Handbooks
• Verlag: Cambridge University Press
• Seitenzahl: 404
• Erscheinungstermin: 2. September 2021
• Englisch
• Abmessung: 198mm x 129mm x 22mm
• Gewicht: 438g
• ISBN-13: 9781009009898
• ISBN-10: 1009009893
• Artikelnr.: 61260642

Autorenporträt

Jonathan M. Meyer is a Clinical Professor of Psychiatry at the University of California, San Diego, and a Psychopharmacology Consultant to the California Department of State Hospitals.

Inhaltsangabe

Preface
Introduction
1. Sampling times for oral and long-acting injectable agents
2. The therapeutic threshold and the point of futility
3. Level interpretation including laboratory reporting issues, responding to high plasma levels, special situations (hepatic dysfunction, renal dysfunction and hemodialysis, bariatric surgery)
4. Tracking oral antipsychotic adherence
5. What is an adequate antipsychotic trial - using plasma levels to optimize psychiatric response and tolerability
6. Important concepts about first generation antipsychotics
7. Haloperidol and haloperidol decanoate
8. Fluphenazine and fluphenazine decanoate
9. Perphenazine and perphenazine decanoate
10. Zuclopenthixol and zuclopenthixol decanoate
flupenthixol and flupenthixol decanoate
11. Chlorpromazine, loxapine, thiothixene, trifluoperazine
12. Important concepts about second generation antipsychotics
13. Clozapine
14. Risperidone oral and long-acting injectable, paliperidone oral and long-acting injectable
15. Olanzapine and olanzapine pamoate
16. Aripiprazole, aripiprazole monohydrate and aripiprazole lauroxil
17. Amisulpride, asenapine, lurasidone, brexpiprazole, cariprazine
Appendix Therapeutic threshold, point of futility, AGNP/ASCP laboratory alert level, and average oral concentration-dose relationships.